Android Apple

Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound)

By Yahoo! Finance   |   3 months ago
Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound)

Eli Lilly, a top pharmaceutical company, offers blockbuster drugs like Verzenio and Trulicity. Besides its innovative medicines, Lilly's consistent dividend growth makes it an attractive long-term investment, with potential for further hikes.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.